Coronary response in doxorubicin-induced cardiomyopathy
Field: Cardiology
Recommended citation: Cobet, V., Rotaru, A., et al. (2017). Coronary response in doxorubicin-induced cardiomyopathy. European Journal of Heart Failure, 19 (S1), 165. https://doi.org/10.1002/ejhf.833
Coronary reserve and reactivity traits regarding doxorubicin (Dx) car-diotoxicity are less known comparatively to myocardial contraction and inotropiccapacities.Aim:the in vitro evaluation of coronary response to natural vasotropic agent actionin Dx-induced cardiomyopathy (Dx-CMP).